Prof. Sullivan and Prof. Wood join iPRI

Professor Richard Sullivan is Director of External Affairs at Kings Health Partners Integrated Cancer Centre and Director of the new KHP Centre for Global OncoPolicy & Health, a joint partnership with the European Institute of Oncology. He is also Visiting Professor (Cancer and Public Health) at Universidad Catolica, Santiago de Chile. Richard Sullivan qualified in medicine at St. Marys Hospital, London. Following training in surgery he undertook a PhD and post-doctoral research in cell signalling at University College London. He then worked in a senior role in the pharmaceutical industry before spending 10 years with Cancer Research UK as their clinical director. Richard serves on a number of international advisory boards, e.g. Charite Comprehensive Cancer Centre Berlin, Irish Clinical Oncology Group, Kings College Marjan Centre for Conflict &Conservation, Pfizer Policy Advisory Board and is past UK Director of the Council for Emerging National Security Affairs (CENSA), a Washington-based national security think-tank. His current research programmes cover the social and political policy of cancer (OncoPolicy), including e-policy and global public health challenges in transitional, high-risk conflict areas focusing on DR Congo, Afghanistan and Libya.

Professor William Wood is a graduate of Harvard Medical School.  He completed a residency in surgery at the Massachusetts General Hospital and a fellowship in surgical oncology at the National Cancer Institute.  He is currently Professor of Surgery at Emory University School of Medicine in the division of Surgical Oncology in the Winship Cancer Institute.  He has devoted his research efforts to oncology, first in the immunology of autoantibodies to tumour-associated antigens, then in clinical trials of the multimodality treatment of breast cancer.  He has served as Chair of the Cancer and Leukaemia Group B Breast Committee, the Eastern Cooperative Oncology Breast Committee, the NCI Breast Intergroup, and Co-Chair of the NCI Breast Cancer Steering Committee, the Early Breast Cancer Trialists’ Collaborative Group [Oxford], and BIG-NABCG.  He has been a Governor of the American College of Surgeons, a Director of the American Society of Clinical Oncology, and the Christian Medical Association, a member of the Board of Scientific Advisors of the NCI, and President of the Society of Surgical Oncology, the South-eastern Surgical Congress, the Georgia Surgical Association, and the Southern Surgical Association.